July 28, 2017 5:52 am JST

Sysmex, Eisai teaming up on Alzheimer's blood test

Less-burdensome diagnoses seen promoting early detection

OSAKA -- Medical device manufacturer Sysmex and drugmaker Eisai will develop a blood test for Alzheimer's disease, with the Japanese duo aiming to bring associated devices to market in two years.

The test will detect the beta-amyloids that accumulate in the brains of Alzheimer's patients. Buildup is thought to be a cause of the cognition-sapping illness. Sysmex and Eisai have developed a high-resolution fluorescence microscope that can make out protein structures, along with other equipment needed for testing.

Eisai will confirm the commercial viability of the equipment using blood from patients at various stages. In two years' time, the partners will sell the systems to university hospitals and research institutions for them to field-test the devices in medical environments. Pricing has not been set.

The new technique could spot Alzheimer's in its early stages better than a doctor could using the conventional in-person examination. Early detection is also possible via PET scans or cerebrospinal fluid, but these are expensive and taxing on the patient.

The blood test could also prove a boon for Eisai and other pharmaceutical companies racing to develop potent Alzheimer's treatments. It is believed that such drugs would need to be administered early for maximum efficacy.

The world's 46.8 million people with dementia in 2015 could nearly triple to roughly 132 million in 2050, according to Alzheimer's Disease International.

(Nikkei)

Sysmex Corp.

Japan

Market(Ticker): TKS(6869)
Sector:
Industry:
Health Technology
Medical Specialties
Market cap(USD): 15,412.20M
Shares: 208.72M

Eisai Co., Ltd.

Japan

Market(Ticker): TKS(4523)
Sector:
Industry:
Health Technology
Pharmaceuticals: Other
Market cap(USD): 16,737.87M
Shares: 296.56M

Get Insights on Asia In Your Inbox

To read the full story, Subscribe or Log in

Get your first month for $0.99

Redeemable only through the Subscribe button below

Once subscribed, you can…

  • Read all stories with unlimited access
  • Use our smartphone and tablet apps

To read the full story, Subscribe or Log in

3 months for $9
SUBSCRIBE TODAY

Take advantage of this limited offer.
Subscribe now to get unlimited access to all articles.

To read the full story, Update your account

Resubscribe now to continue reading.
BEST OFFER:
Only US$ 9.99 per month for a full-year subscription

To read the full story, Subscribe or Log in

Once subscribed, you can…

  • Read all stories with unlimited access
  • Use our smartphone and tablet apps

To read the full story, Subscribe or Log in

3 months for $9
SUBSCRIBE TODAY

Take advantage of this limited offer.
Subscribe now to get unlimited access to all articles.

To read the full story, Update your account

We could not renew your subscription.
You need to update your payment information.